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CYTOCHROME c, a 14-kDa hemoprotein that normally resides in the outer surface of the inner mitochondrial membrane bound to cardiolipin (34) , plays a key physiological role in oxidative phosphorylation as electron carrier between cytochrome c reductase (complex III) and cytochrome c oxidase (complex IV). However, cytochrome c can also translocate out of the mitochondria to the cytosol under various pathological conditions, such as ultraviolet irradiation (21) , serum and glucose deprivation (9) , exposure to H 2 O 2 or superoxide anion (O 2 Ϫ ) (44), Ca 2ϩ overload (35) , and hypoxia (16) . In the cytosol, cytochrome c forms an oligomeric complex with 2-deoxy-ATP and apoptotic protease activating factor-1 (30) . This complex recruits procaspase-9, forming what is known as the apoptosome, leading to cleavage and release of active caspase-9, which in turn cleaves and activates executioner caspases-3, -6, and -7 (10, 39, 48) . The subsequent fate of cytochrome c is less well known. Recent studies in Jurkat leukemic T cells and mouse fibroblasts suggest that cytochrome c leaves the cell and is detected in the extracellular milieu through mechanisms apparently unrelated to cell necrosis (37, 46) . In patients, elevated levels of circulating cytochrome c have been reported in association with conditions that can injure mitochondria, such as chemotherapy (6, 37) , acute myocardial infarction (2) , fulminant hepatitis (38) , systemic inflammatory response syndrome (1) , and influenza-associated encephalopathy (24, 25) .
Our work has focused on cardiac arrest and resuscitation, in which ischemia and reperfusion are at the core of the pathogenic process. Ischemia and reperfusion cause intracellular Ca 2ϩ overload (42) and generation of reactive oxygen species (3), conditions that, as indicated above, predispose to mitochondrial injury and cytochrome c release. We therefore hypothesized that mitochondria are injured during cardiac arrest and resuscitation, prompting the release of cytochrome c, with activation of apoptotic pathways and appearance in the bloodstream. Given the fundamental role of cytochrome c as electron carrier and its detrimental downstream effects after release to the cytosol, we further hypothesized that levels of plasma cytochrome c may indicate development of organ dysfunction and relate inversely with survival outcome. We tested these hypotheses in a well-standardized rat model of electrically induced ventricular fibrillation (VF) and closed-chest resuscitation (18, 22, 29) .
MATERIALS AND METHODS
The studies were approved by our Institutional Animal Care and Use Committee and conducted in accordance with institutional guidelines.
Animal Preparation
Adult male Sprague-Dawley rats (480 -550 g body wt) were anesthetized using pentobarbital sodium (45 mg/kg ip for induction and 10 mg/kg iv every 30 min for maintenance). A 5-Fr cannula was advanced orally into the trachea and used for positive-pressure ventilation during cardiac resuscitation and the postresuscitation interval. Proper placement was verified using an infrared CO 2 analyzer (CO 2SMO model 7100, Novametrix Medical Systems). A conventional lead II ECG was recorded through subcutaneous needles. PE-50 catheters were advanced through the right femoral vein into the right atrium, from the right carotid into the left ventricle, and from the left femoral artery into the abdominal aorta for pressure measurement and blood sampling. A thermocouple microprobe (model IT-18, Physitemp) was advanced through the right femoral artery into the thoracic aorta for thermodilution cardiac output measurement. A PE-50 catheter was advanced through the left external jugular vein into the right atrium and used exclusively for injection of thermal tracer. A 3-Fr catheter (model C-PUM-301J, Cook) was advanced through the right external jugular vein into the right atrium, and through its lumen a precurved guide wire was fed into the right ventricle for electrical induction of VF. Core temperature was maintained at 36.5-37.5°C with an infrared heating lamp.
VF and Resuscitation Protocol
VF was induced by delivery of a 60-Hz alternating current to the right ventricular endocardium (0.1-0.6 mA) for an uninterrupted interval of 3 min, the current was turned off, and VF was allowed to continue until completion of a predetermined interval (see below). Chest compression was then begun using an electronically controlled and pneumatically driven (50 psi) chest compressor (model CJ-80623, CJ Enterprises) set to deliver 200 compressions/min with a 50% duty cycle. The depth of compression was adjusted to attain an aortic diastolic pressure of 26 -28 mmHg, ensuring a coronary perfusion pressure above the resuscitability threshold of 20 mmHg in rats (18, 45) . Positive-pressure ventilation was provided using an electronically controlled solenoid valve (model R-481, Clippard Instrument Laboratory) set to deliver 0.39 ml/100 g body wt of 100% oxygen every two compressions. Defibrillation was attempted after 8 min of chest compression by delivery of a maximum of two 2-J monophasic transthoracic shocks (Lifepak 9P, Physio-Control). If VF persisted or an organized rhythm with a mean aortic pressure of Յ25 mmHg ensued, chest compression was resumed for 30 s. The defibrillationcompression cycle was repeated up to three additional times, with an increase in the energy of individual shocks to 4 J if VF persisted and an increase to 8 J for the last two cycles. Successful resuscitation was defined as the return of an organized cardiac rhythm with a mean aortic pressure Ն60 mmHg for Ն5 min. Resuscitated rats were ventilated initially with 100% O 2 for 15 min and with 50% O2 for the remaining postresuscitation interval.
Experiments
Two series of experiments were conducted. In series 1, changes in plasma cytochrome c were measured for up to 240 min after resuscitation in fully instrumented rats (see above). In series 2, changes in plasma cytochrome c were measured for up to 96 h after resuscitation in rats that were minimally instrumented to facilitate survival (see below). Series 1. Three groups of four rats each were investigated. Two groups were subjected to 4 or 8 min of untreated VF followed by 8 min of closed-chest resuscitation before defibrillation was attempted and observed for Յ240 min after resuscitation. One group, which received identical treatment, except for VF and closed-chest resuscitation, served as the sham group. Rats were randomized to the experimental assignment immediately after completion of surgical preparation.
Series 2. The animal preparation for series 2 differed from that for series 1, in that hemodynamic measurements were limited to right atrial and aortic pressures by advancing PE-50 tubing from the left jugular vein into the right atrium and from the left carotid artery into the descending thoracic aorta. Additional surgical manipulation was avoided, except for the 3-Fr catheter (model C-PUM-301J, Cook) and guide wire required for induction of VF. Core temperature was measured through a rectal thermistor. During closed-chest resuscitation, rats were ventilated using a volume-controlled ventilator (model 683, Harvard Apparatus) set to deliver 6 ml/kg at 25 breaths/min unsynchronized to chest compression. For defibrillation, a biphasic waveform defibrillator (Heartstream XL, Philips Medical Systems) was used to deliver 3, 5, and 7 J as needed according to series 1 protocol. These changes reflected implementation of new developments in cardiac resuscitation. After 240 min of resuscitation, rats were allowed to recover from anesthesia. The left carotid PE-50 tubing was replaced with soft PE-50 tubing primed with heparinized glycerol. The proximal end was sealed with a metal plug that could be removed for blood sampling and tunneled under the skin to the interscapular region, where a skin incision held closed by a removable metal clip allowed intermittent access. For blood sampling, rats were anesthetized using isoflurane (0.5-1.0%) and 100% oxygen, and arterial blood (200 l) was collected into a heparinized syringe. A total of 12 rats were successfully resuscitated after 8 min of untreated VF and 8 min of closed-chest resuscitation. Cytochrome c was serially measured until the rat died or cytochrome c returned to baseline levels.
Additional experiments were performed after documentation of prominent increases in postresuscitation plasma cytochrome c levels to determine 1) in vitro, whether cytochrome c could induce apoptosis in circulating leukocytes and 2) in vivo, whether plasma cytochrome c could reflect increased apoptotic activity of leukocytes, notwithstanding evidence suggesting that, in other acute settings such as acute respiratory distress syndrome (31) , sepsis (33) , and burn injury (12) , apoptosis is suppressed in neutrophils. Apoptosis was investigated using flow cytometry to detect exteriorization of phosphatidylserine in total leukocytes, neutrophils, and lymphocytes (43) .
For in vitro studies, 5 ml of blood were collected through PE-50 tubing advanced from the left carotid artery into the descending thoracic aorta in adult male Sprague-Dawley rats. Blood was heparinized (30 U/ml), and 300-l aliquots were incubated with rat heart cytochrome c at 0, 2 and 10 g/ml at 37°C for 4 h in an incubator shaker (model I2400, New Brunswick Scientific). For in vivo studies, rats were subjected to 8 min of untreated VF followed by closed-chest resuscitation as described for series 2 and monitored until they died. Arterial blood was collected when the mean aortic pressure decreased below 40 mmHg. Blood samples were processed for flow cytometry as described below.
Materials
Acetonitrile (ACN), EDTA, HEPES, mannitol, propidium iodide (PI), rat heart cytochrome c, sucrose, trifluoroacetic acid (TFA), and mouse monoclonal anti-␤-actin antibody were purchased from Sigma; 1-mm-thick 12% and 14% Novex Tris-glycine polyacrylamide gels from Invitrogen; polyvinylidene difluoride membranes from Roche Applied Science; rabbit polyclonal anti-cytochrome c and rabbit polyclonal anti-caspase-3 antibodies from Cell Signaling Technology; mouse monoclonal anti-prohibitin antibody from Calbiochem; annexin V conjugated with fluorescein isothiocyanate (FITC) and mouse-monoclonal anti-cytochrome c antibody (clone 7H8.2C12) from BD Biosciences PharMingen; Immunolyse (red blood cell lysis agent) from Coulter; and goat polyclonal anti-rabbit IgG and goat polyclonal anti-mouse IgG horseradish peroxidase (HRP)-conjugated antibodies, bicinchoninic acid protein concentration assay kit, and West femto maximum sensitivity chemiluminescent detection kit from Pierce Biotechnology.
Hemodynamic Measurements
Continuous physiological measurements were transduced, conditioned (BIOPAC Systems), and digitized at 250 scans/s using a 16-bit data acquisition board (model AT-MIO-16XE-50, National Instruments). Systemic and left ventricular pressures were obtained through fluid-filled systems attached to disposable pressure transducers (Maxxim Medical) zeroed to midchest level. Cardiac output was measured by thermodilution after a right atrial bolus injection of 200 l of 0.9% NaCl at room temperature and curve analysis using custom-developed LabVIEW-based software. Cardiac index (CI) was calculated by normalization of cardiac output (in ml/min) to body weight (in kg).
The stroke volume index was calculated by dividing CI by heart rate. Left ventricular stroke work index (LVSWI) was calculated by multiplying the stroke volume index by the difference between left ventricular systolic and diastolic pressures.
Plasma Cytochrome c
Arterial blood samples (200 l) were collected into heparinized syringes and centrifuged at 5,000 rpm (2,320 g) for 10 min at 4°C (Sorvall Biofuge Stratos, Heraeus). The supernatant (plasma) was frozen at Ϫ80°C for later analysis using reverse-phase high-performance liquid chromatography (HPLC) and Western immunoblotting in series 1 but used immediately for analysis by HPLC in series 2.
HPLC. A reverse-phase HPLC technique previously used to measure cytochrome c in mitochondrial suspension and cytosol (15, 36) was adapted for measurement of cytochrome c in plasma. Samples were first treated with 1:1 (vol/vol) 50% ACN solution-0.1% TFA (ACN-TFA) and then centrifuged at 5,000 rpm (2,320 g) for 10 min to precipitate high-molecular-mass plasma proteins. Cytochrome c was measured in the supernatant using a Beckman HPLC system equipped with a Jupiter C-4 reverse-phase analytic column (150 ϫ 4.6 mm, 5 m; Phenomenex) preceded by a guard column [4.0 ϫ 3.0 mm, widepore C-4 (butyl) column, SecurityGuard, Phenomenex], an ultraviolet-visible light spectroscopic detector, and Beckman System Gold software. After the mobile phase was programmed to provide a constant-flow (1.0 ml/min) linear gradient starting at 20% ACN-TFA and increasing to 60% ACN-TFA over a 15-min interval, the sample was washed for 5 min in 60% ACN-TFA and allowed to equilibrate for 5 min in 20% ACN-TFA. Each sample (20 l) was loaded in an injection loop and automatically delivered into the mobile phase at the start of the linear gradient. Absorbance was measured at 393 nm. For quantification of plasma cytochrome c levels, standard curves (0.2-20 g/ml) were prepared using rat heart cytochrome c dissolved in plasma from pentobarbital sodium-anesthetized rats not subjected to surgical manipulation (Fig. 1A) . In vivo increases in cytochrome c were confirmed by serial plasma measurements after injection of 5 mg/kg of rat heart cytochrome c during spontaneous circulation (Fig. 1B) .
Western immunoblotting. Western immunoblotting was performed as previously described by Ausubel et al. (5) and Harlow and Lane (23) . Plasma samples were thawed on ice, and 8 l were resolved in 1-mm-thick 12% Novex Tris-glycine polyacrylamide gel. After electrophoresis, a wet electroblotting apparatus (Hoefer TE22, Amersham Pharmacia Biosciences) was used to transfer the fractionated proteins to a polyvinylidene difluoride membrane. After transfer, the blots were blocked and incubated at 4°C overnight with rabbit polyclonal anti-cytochrome c antibody (1:2,000 dilution) and then with goat polyclonal anti-rabbit IgG HRP-conjugated antibody (1:1,000 dilution) for 1 h at room temperature. Chemiluminescence was documented in X-ray film. Protein molecular mass markers were run simultaneously in each gel. The specificity of the cytochrome c band was based on molecular mass along with positive and negative controls.
Western Immunoblotting of Left Ventricular Tissue
Hearts from series 1 experiments were harvested 240 min after resuscitation or earlier if hemodynamic deterioration occurred (i.e., a decrease in mean aortic pressure below 40 mmHg in 2 instances). The right ventricle and atria were removed, and the left ventricle was frozen in liquid N 2 and stored at Ϫ80°C until analysis. For assessment of cytochrome c release, subcellular fractions were separated by the technique of Ott et al. (34) with minor modifications and subjected to Western immunoblotting. Briefly, left ventricular tissue (ϳ100 mg) was homogenized (Dounce homogenizer) in 2 ml of MSH buffer [210 mM mannitol, 70 mM sucrose, 5 mM HEPES (pH 7.4), and 1 mM EDTA (pH 8)] and centrifuged at 1,000 g for 10 min to pellet nuclei and debris. The resulting supernatant was centrifuged at 10,000 g for 30 min. The pellet containing mitochondria was washed and resuspended in MSH buffer. The supernatant was further centrifuged at 33,000 g for 3.3 h, and the resulting supernatant, representing the cytosolic fraction, was collected. Both fractions were stored at Ϫ80°C until analysis. The protein concentration in each fraction was determined by the bicinchoninic acid kit. Mitochondrial and cytosolic fractions (20 g each) were resolved in 1-mm-thick 12% Novex Tris-glycine polyacrylamide gel and immunoblotted as described above for plasma cytochrome c. Cytochrome c was probed using a mouse monoclonal anti-cytochrome c antibody (1:4,000 dilution). Prohibitin, a 30-kDa inner mitochondrial membrane protein, and ␤-actin were selected as loading controls for mitochondrial and Fig. 1 . Plasma cytochrome c measured by HPLC. A: standard curve. Rat heart cytochrome c was dissolved in plasma from pentobarbital sodium-anesthetized rats that were not subjected to surgical manipulation. Absorbance was measured at 393 nm (ambient temperature), and peak area was determined by integration of the beginning to the end of the chromatographic peak center at ϳ9.5 min of retention time (arrows in B and C). Solid line, linear fit of the data (r 2 ϭ 0.9996). B: plasma cytochrome c detected in chromatographs of plasma obtained before and after right atrial injection of cytochrome c (5 mg/kg) during spontaneous circulation in a 500-g rat. C: representative chromatographs of plasma from a 506-g rat resuscitated after 8 min of untreated ventricular fibrillation (VF). Death of the rat 8.5 h after resuscitation (PR) was preceded by a progressive rise in plasma cytochrome c. A393 nm, absorbance at 393 nm; BL, baseline. cytosolic fractions, respectively. Prohibitin was probed using a mouse monoclonal anti-prohibitin antibody (1:1,000 dilution). ␤-Actin was probed using a mouse monoclonal anti-␤-actin antibody (1:2,500 dilution). The blots were incubated with the primary antibodies for 3 h at room temperature and then with HRP-conjugated goat polyclonal anti-mouse IgG (1:1,000 dilution) for 1 h at room temperature and documented by chemiluminescence.
For assessment of caspase-3 activation, 100 mg of left ventricular tissue were homogenized in 0.4 ml of MSH buffer with a homogenizer (Mixer Mill, model MM200, Retsch). The cytosolic fraction (100 g) was separated by subcellular fractionation as described above and subjected to 14% gel electrophoresis and Western immunoblotting using rabbit polyclonal anti-caspase-3 antibody (1:1,000 dilution), which recognizes 35-kDa procaspase-3 and its 19-and 17-kDa cleaved fragments (32) . For loading controls, ␤-actin was used as described above.
Detection of Leukocyte Apoptosis by Flow Cytometry
During apoptosis, phosphatidylserine, which normally resides in the cytoplasmic side of cell membranes, translocates to the extracellular side (20) . This step is characteristic of early apoptosis (preceding DNA fragmentation) and is used to detect apoptosis on the basis of annexin V binding to phosphatidylserine (43) . Annexin V, a 36-kDa Ca 2ϩ -dependent phospholipid-binding protein with high affinity for phospholipid bilayers containing phosphatidylserine (4), is used in various apoptosis assays, commonly in conjunction with the vital dye PI, to concomitantly assess disruption of plasma membrane. In the present studies, blood was incubated with annexin V-FITC and PI and then subjected to flow cytometry to detect cells that bind annexin V and those that bind PI (43) .
Blood labeling. Labeling with annexin V-FITC and PI was performed according to Van Oostveldt et al. (41) with modifications. Briefly, blood samples (100 l) were washed first with PBS and then with annexin V binding buffer [10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl 2 (pH 7.4)]. The buffers were removed by centrifugation at 370 g for 5 min, and the pellets were suspended in 100 l of annexin V binding buffer. Annexin V-FITC (5 l) was added, and the samples were protected from light and incubated for 15 min at room temperature. The samples were then washed with PBS containing 2.5 mM CaCl 2 for removal of unbound annexin V-FITC. Red blood cells were lysed using 1 ml of Immunolyse diluted in PBS (1:24 dilution). The samples were then centrifuged at 370 g for 5 min, and the pellets were resuspended in 400 l of PBS containing 2.5 mM CaCl 2. PI was added to a final concentration of 2.5 ng/l, and the sample was incubated on ice for 5-10 min before immediate analysis. All other samples were analyzed within 1 h. Unstained, single-stained (annexin V-FITC or PI), and double-stained (annexin V-FITC and PI) samples were used to adjust compensation and to set horizontal and vertical cursors on the two-parameter dot-plot.
Flow cytometry. A FACSCalibur cytometer (Becton Dickinson) equipped with a 488-nm argon ion laser was used for flow cytometry. The total leukocyte population was gated on the basis of cell size (forward scatter) and granularity (side scatter), identifying two separate gates corresponding to neutrophils and lymphocytes. The FITC and PI fluorescence signals were detected using 530-and 585-nm band-pass filters, respectively. Two-dimensional fluorescence dot-plot profiles representing ϳ10,000 gated events for total leukocytes and proportionally fewer events for the subpopulations of neutrophils and lymphocytes were generated. The data were analyzed using CellQuest Pro software (Becton Dickinson).
Statistical Analysis
Differences among groups for continuous variables were analyzed using one-way ANOVA and Holm-Sidak's test for multiple comparisons. Alternative nonparametric tests were used if the data failed tests for normality or equal variance. The strength of association between variables was analyzed using Pearson's product-moment correlation test. Values are means (SD) unless otherwise stated. Two-tailed P Ͻ 0.05 was considered significant.
RESULTS

Series 1
Baseline hemodynamic measurements were comparable among groups. After resuscitation, rats subjected to VF developed characteristic postresuscitation myocardial dysfunction, evidenced by persistently low mean aortic pressure and progressive reductions in LVSWI and CI without measurable differences related to the duration of untreated VF (Fig. 2) . Myocardial dysfunction accounted for early death of one rat subjected to 4 min of untreated VF (at 150 min) and one rat subjected to 8 min of untreated VF (at 155 min). As previously reported, cardiac arrest and resuscitation were associated with anaerobic metabolism, evidenced by prominent increases in arterial lactate and reductions in arterial bicarbonate. Arterial lactate was maximal after return of spontaneous circulation and gradually decreased toward baseline during the postresuscitation interval (Fig. 3) .
Plasma cytochrome c rose progressively during the postresuscitation interval in rats subjected to VF, with a statistically significant difference from sham rats beginning 30 min after resuscitation (Fig. 3) . Western immunoblotting confirmed elevated levels of cytochrome c in plasma during the postresuscitation interval (Fig. 4) . The plasma levels of cytochrome c were inversely correlated with LVSWI (r ϭ Ϫ0.40, P ϭ 0.02, for 38 measurements obtained at 5 postresuscitation events in 8 resuscitated rats).
In left ventricular tissue, higher values for cytochrome c were observed in cytosolic and mitochondrial fractions proportional to the injury, but the differences were not statistically significant (Figs. 5A and 6 ). The level of 17-kDa caspase-3 fragments measured in the cytosolic fraction, however, was significantly increased in rats resuscitated from VF (Figs. 5B and 6).
Series 2
Of 12 successfully resuscitated rats, 3 survived for Ͼ24 h and were euthanized according to the protocol after 70 -96 h. In this group, cytochrome c rose gradually to Յ2 g/ml and then returned to baseline levels (Fig. 7) . The remaining nine rats died 1.3-32.5 h after resuscitation, with a progressive rise in plasma cytochrome c (Figs. 1C and 7 
Leukocyte Apoptosis
Flow cytometry scattergrams of total leukocytes, neutrophils, and lymphocytes at baseline and after resuscitation are shown in Fig. 8 . The aggregate data from the in vitro and in vivo studies are shown in Table 2 . The in vitro studies show that incubation with increasing concentrations of cytochrome c (Յ10 g/ml) did not induce apoptosis in total leukocytes, neutrophils, or lymphocytes, as evidenced by a comparably low percentage of annexin Vϩ/PIϪ and annexin Vϩ/PIϩ cells. The in vivo studies showed a decreased percentage of annexin Vϩ/PIϪ neutrophils after resuscitation, but not in lymphocytes, in which the level of apoptosis was already low. The plasma cytochrome c levels measured by HPLC in these rats corresponded to 0.13 g/ml (SD 0.18) at baseline and 2.36 g/ml (SD 0.74) after resuscitation.
DISCUSSION
The present study demonstrates for the first time in a rat model of VF and closed-chest resuscitation that cytochrome c is released into the bloodstream after resuscitation from cardiac arrest. Release of cytochrome c was associated with activation of the executioner caspase-3, impaired left ventricular function, 4 . Western immunoblots of plasma cytochrome c using rabbit polyclonal anti-cytochrome c primary antibody (1:2,000 dilution) and goat polyclonal anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (1:1,000 dilution) in 3 representative experiments in which 8 l of plasma were loaded in each lane. Plasma cytochrome c levels remained unchanged in sham controls but progressively rose in rats subjected to VF. Negative control (nc) was obtained from cytochrome c-positive rat plasma (240 min after resuscitation) in which the primary antibody was omitted. Positive control (pc) represents antibody reactivity to rat heart cytochrome c. and decreased survival. Accordingly, measurement of cytochrome c in plasma may serve as an in vivo marker of mitochondrial injury that inversely relates to survival outcome.
Cytochrome c Release to the Cytosol
Release of cytochrome c to the cytosol is an important pathogenic event that signals activation of the intrinsic (or mitochondrial) apoptotic pathway, with subsequent activation of executioner caspases. In the present studies, we documented activation of the executioner caspase-3 in the cytosol of left ventricular tissue by detection of 17-kDa cleaved fragments. Caspase-3 activation was associated with numerical increases in cytosolic and mitochondrial cytochrome c. Additional work is underway in our laboratory to validate these tissue findings, explore possible participation of the extrinsic apoptotic pathway, and examine the downstream effect of caspase activation, bearing in mind that apoptotic death is one of many other possible cell effects, some of which may not be lethal and may explain reversible dysfunction (13, 40) . The possibility of increased mitochondrial cytochrome c after resuscitation is intriguing but consistent with recent studies reporting upregulation of genes encoding for proteins of the respiratory chain during apoptosis (11) .
Various mechanisms have been proposed to explain how cytochrome c is released from the mitochondria. One mechanism involves opening of a high-conductance megachannel. This channel, known as the mitochondrial permeability transition pore (MPTP) (14) , forms by apposition of at least three major proteins, including adenine nucleotide translocator, voltage-dependent anion channel, and cyclophilin D (14) , and enables Յ1.5-kDa molecules to pass through the channel. MPTP opening in vitro causes mitochondrial swelling, with disruption of the outer mitochondrial membrane and release of cytochrome c (14, 47) . However, it is not clear whether swelling occurs in vivo. Another mechanism involves selective permeabilization of the outer mitochondrial membrane without MPTP opening. Proapoptotic and antiapoptotic proteins of the ␤-cell leukemia/lymphoma-2 (Bcl-2) family play a critical role, given their ability to form channel-like structures when proapoptotic members translocate to the outer mitochondrial membrane (19, 28) . Cytochrome c release is facilitated by concurrent peroxidation of cardiolipin by reactive oxygen species. Peroxidation of cardiolipin decreases its binding affinity for cytochrome c, creating a soluble pool that can be released to the cytosol (34) .
The specific mechanism(s) responsible for cytochrome c release in our experimental model is not known. It is conceivable that a particular mechanism of cytochrome c release may relate to the type and severity of tissue injury. For instance, MPTP opening, but not outer mitochondrial membrane permeabilization, causes collapse of the mitochondrial voltage gradient, leading to uncoupling of oxidative phosphorylation and cessation of ATP production (17) .
Cytochrome c Release to the Bloodstream
The mechanism by which cytosolic cytochrome c reaches the extracellular space and appears in the bloodstream is not well understood. Several studies have shown that cytochrome c release outside the cell occurs without concomitant release of larger molecules, such as lactate dehydrogenase, which is considered a marker of cell necrosis, with disruption of the cell membrane (1, 6, 7, 37) . Regardless of the mechanisms, our study demonstrated a progressive rise in plasma cytochrome c during the postresuscitation period to levels that were inversely related to survival outcome. Cytochrome c levels increased after return of spontaneous circulation, despite reversal of whole body ischemia. This would suggest that ischemia and reperfusion trigger processes leading to a progressive rise in plasma cytochrome c after return of metabolically adequate blood flow. The specific organs that contributed to circulating cytochrome c were not determined in this study. Organs rich in mitochondria, with a high metabolic rate and a propensity to ischemia-and-reperfusion injury, such as the heart and brain, are likely candidates. However, without knowing the specific mechanisms of cytochrome c release, especially after return of spontaneous circulation, we cannot exclude other mitochondriarich organs, such as the liver, kidney, pancreas, and skeletal muscle. The possibility that plasma cytochrome c was contributed by circulating blood cells was considered. Circulating red blood cells contain a considerable amount of caspase-3; however, they lack nuclei, mitochondria, and the machinery for activation of apoptotic pathways (8) . Neutrophils, on the other hand, can undergo apoptosis. However, studies have shown that apoptosis in neutrophils is actually delayed under conditions such as acute respiratory distress syndrome (31), sepsis (33) , and burn injury (12) . Huda et al. (27) demonstrated no signs that apoptosis is activated in neutrophils after tourniquetinduced ischemia in human skeletal muscle 4 h after reperfusion. Acute stress seems to suppress the mitochondrial apoptotic pathway of neutrophils consequent to downregulation of proapoptotic Bcl-2 proteins (26) . Similarly, we found in the present studies that the percentage of neutrophils undergoing apoptosis is reduced after resuscitation from cardiac arrest and that increased levels of cytochrome c are not likely to induce apoptosis in leukocytes. Accordingly, the increased plasma levels of cytochrome c in the present studies most likely originated from organs that suffered ischemia and reperfusion injury during cardiac arrest and resuscitation.
Significance
Our studies suggest that levels of circulating cytochrome c could serve as an in vivo marker of mitochondrial injury and organ damage (i.e., left ventricular dysfunction) and prognosticate survival after resuscitation from cardiac arrest. Recently, similar observations were made in patients with a wide variety of critical conditions. For example, Adachi et al. (1) reported a rapid rise in serum cytochrome c in survivors of systemic inflammatory response syndrome and multiorgan dysfunction syndrome, with higher levels in patients who did not survive. Similarly, levels of cytochrome c were significantly higher in nonsurvivors of influenza-associated encephalopathy than in survivors (25) . A similar negative predictive value of serum cytochrome c has been reported in patients presenting with fulminant hepatitis (38). We conclude that cardiac arrest and resuscitation trigger events leading to progressive and prominent increases in circulating cytochrome c. We propose that plasma cytochrome c may represent a novel in vivo marker of mitochondrial injury during resuscitation from cardiac arrest that could serve to quantitate the severity of injury, prognosticate survival outcomes, and act as a surrogate measurement for gauging the effects of therapeutic interventions.
